Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Clinical Trials

18 clinical trials for Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Cohort Study on Neuroimmune Diseases in the Reproductive Age — RECRUITING
• The Italian Multiple Sclerosis and Related Disorders Register — RECRUITING
• Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study. — RECRUITING
• Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging — RECRUITING
• Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD) — RECRUITING
• Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System — RECRUITING · PHASE1
• Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD) — RECRUITING · NA
• Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases — RECRUITING
• MS-ResearchBiomarkerS — RECRUITING
• A PHASE III, RANDOMIZED, DOUBLE¿BLIND, PLACEBO¿CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB AS MONOTHERAPY OR IN ADDITION TO BASELINE THERAPY IN PATIENTS WITH MYELIN OLIGODENDROCYTE GLYCOPROTEIN-ANTIBODY-ASSOCIATED DISEASE (MOGAD). — RECRUITING · PHASE3
• A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOGAD) — ACTIVE_NOT_RECRUITING · PHASE3
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease — ACTIVE_NOT_RECRUITING · PHASE3
• A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 3, Pivotal Study With an Open-Label Extension Period to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOG-AD) — TERMINATED · PHASE3
• A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SATRALIZUMAB AS MONOTHERAPY OR IN ADDITION TO BASELINE THERAPY IN PATIENTS WITH MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-ASSOCIATED DISEASE (MOGAD) — TERMINATED · PHASE3
• Tongji NADs Cohort — NOT_YET_RECRUITING
• Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease — ACTIVE_NOT_RECRUITING · PHASE2
• National, Multicentric Registry Study on Neuroimmunological Diseases in China — OTHER
• Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve — OTHER

Refine this search